PAVmed Inc. — Director's Dealing 2017

Feb 15, 2017

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2016-12-31

Reporting Person: Greenspan Ira Scott (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-18	Common Stock	L	200	$10.20	Acquired	28465	Direct
2016-11-23	Common Stock	L	110	$8.9867	Acquired	28465	Direct
2016-12-09	Common Stock	L	282	$8.4719	Acquired	28465	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-18	Warrants	$5.00	L	100	Acquired	2022-01-29	Common Stock (100)	Direct
2016-12-09	Warrants	$5.00	L	320	Acquired	2022-01-29	Common Stock (320)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5713879	Indirect
Common Stock	20904	Indirect
Common Stock	87020	Indirect
Common Stock	125000	Indirect
Common Stock	20000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$5.00	2022-01-29	Common Stock (5713879)	5713879	Indirect
Warrants	$5.00	2022-01-29	Common Stock (6968)	6968	Indirect
Warrants	$5.00	2022-01-29	Common Stock (387020)	387020	Indirect
Warrants	$5.00	2022-01-29	Common Stock (125000)	125000	Indirect
Warrants	$5.00	2022-01-29	Common Stock (20000)	20000	Indirect

Footnotes

F1: The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $8.5535 to $9.0300, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.

F2: The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.6780 to $8.9990, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.

F3: Mr. Greenspan is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.

F4: Robert M. Greenspan is the reporting person's son.

F5: Mr. Greenspan is a controlling shareholder of HCFP Inc., and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.

F6: Mr. Greenspan is a member and a co-manager of the entity that acts as sole manager of HCFP/Capital Partners IIIB LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein.

F7: Mr. Greenspan is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein.

F8: The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.9875 to $7.4900, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants acquired at each separate price within the ranges set forth in this footnote.